SCHEMBL30844081

SCHEMBL30844081

C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.45
▸ MAPK9 P45984 1/20 0.45
▸ MAPK10 P53779 1/20 0.45
▸ NPY2R P49146 6/20 0.40
▸ NPY4R P50391 6/20 0.40
▸ NPY5R Q15761 6/20 0.40
▸ NPY1R P25929 4/20 0.40
▸ RAMP3 O60896 5/20 0.40
▸ CALCR P30988 5/20 0.40
▸ OPRM1 P35372 6/20 0.40
▸ OPRK1 P41145 6/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29530519 0.91 EPHA2 (0.50) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL31265332 0.89 ACE (0.43) OPRM1OPRK1
SCHEMBL29801687 0.88 OPRM1 (0.47) OPRM1OPRK1
SCHEMBL30868640 0.87 NMUR2 (0.44) MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL30957282 0.87 EPHA2 (0.49) MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL30571159 0.87 MAPK8 (0.51) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL31066830 0.87 MAPK8 (0.56) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL31593308 0.86 OPRM1 (0.41) OPRM1OPRK1
SCHEMBL30868607 0.86 RAMP3 (0.46) MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL31031598 0.85 RAMP3 (0.48) MAPK8MAPK9MAPK10NPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820469-A anti-Slc 17a2 monoclonal antibody and application thereof 中国人民解放军空军军医大学 2024-04-05 — — CN claimed
CN-117820469-A anti-Slc 17a2 monoclonal antibody and application thereof 中国人民解放军空军军医大学 2024-04-05 — — CN disclosed
Send feedback